<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=MMP20</id>
	<title>MMP20 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=MMP20"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=MMP20&amp;action=history"/>
	<updated>2026-05-01T16:16:35Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=MMP20&amp;diff=4049&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Matrix metalloproteinase-20 precursor (EC 3.4.24.-) (MMP-20) (Enamel metalloproteinase) (Enamelysin)  ==Publications==  {{medline-entry |title=Identification of t...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=MMP20&amp;diff=4049&amp;oldid=prev"/>
		<updated>2021-04-29T18:58:05Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Matrix metalloproteinase-20 precursor (EC 3.4.24.-) (MMP-20) (Enamel metalloproteinase) (Enamelysin)  ==Publications==  {{medline-entry |title=Identification of t...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Matrix metalloproteinase-20 precursor (EC 3.4.24.-) (MMP-20) (Enamel metalloproteinase) (Enamelysin)&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Identification of the effects of aging-related gene-matrix metalloproteinase on allograft outcomes in kidney transplantation.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/23953525&lt;br /&gt;
|abstract=Aging plays a profound role in the ability of the kidney to function. Aging which varies among individuals, has been associated with the matrix metalloproteinase (MMP) 7 and 20 genes. This study was conducted to analyze correlations between polymorphisms of MMP genes [rs880197 in [[MMP7]] (A&amp;gt;T) and rs1711437 in [[MMP20]] (G&amp;gt;A)] and transplant outcomes in 235 recipients. Transplant outcomes were evaluated according to the sum of the A alleles in the recipients and the donors. The group with a high number of A alleles (≥3) was compared with the group with a low number (&amp;lt;3). The group with a high number of [[MMP7]] A alleles showed a lower risk of chronic tubulointerstitial lesion than the group with a low number (P = .009). The group with a high number of [[MMP20]] A alleles had showed better long-term kidney function at 10 years after transplantation than the group with a low number (P = .026). Furthermore, the group with a high number of [[MMP20]] A alleles showed a trend toward better graft survival compared with the group with a low number, especially among recipients followed for &amp;gt;1 year (P = .022). Polymorphisms of [[MMP7]] and [[MMP20]] genes may be surrogate markers to predict long-term outcomes after kidney transplantation.&lt;br /&gt;
|mesh-terms=* Adult&lt;br /&gt;
* Age Factors&lt;br /&gt;
* Aging&lt;br /&gt;
* Female&lt;br /&gt;
* Gene Frequency&lt;br /&gt;
* Genotype&lt;br /&gt;
* Graft Survival&lt;br /&gt;
* Humans&lt;br /&gt;
* Kidney Transplantation&lt;br /&gt;
* Male&lt;br /&gt;
* Matrix Metalloproteinase 20&lt;br /&gt;
* Matrix Metalloproteinase 7&lt;br /&gt;
* Middle Aged&lt;br /&gt;
* Phenotype&lt;br /&gt;
* Polymorphism, Genetic&lt;br /&gt;
* Risk Factors&lt;br /&gt;
* Time Factors&lt;br /&gt;
* Treatment Outcome&lt;br /&gt;
* Young Adult&lt;br /&gt;
&lt;br /&gt;
|full-text-url=https://sci-hub.do/10.1016/j.transproceed.2013.03.020&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>